Zheng Y, Glaven J A, Wu W J, Cerione R A
Department of Pharmacology, Cornell University, Ithaca, New York 14853, USA.
J Biol Chem. 1996 Sep 27;271(39):23815-9. doi: 10.1074/jbc.271.39.23815.
Members of the Rho subfamily of Ras-related GTP-binding proteins play important roles in the organization of the actin cytoskeleton and in the regulation of cell growth. We have shown previously that the dbl oncogene product, which represents a prototype for a family of growth regulatory proteins, activates Rho subfamily GTP-binding proteins by catalyzing the dissociation of GDP from their nucleotide binding site. In the present study, we demonstrate that the acidic phospholipid, phosphatidylinositol 4,5-bisphosphate (PIP2), provides an alternative mechanism for the activation of Cdc42Hs. Among a variety of lipids tested, only PIP2 was able to stimulate GDP release from Cdc42Hs in a dose-dependent manner, with a half-maximum effect at approximately 50 microM. Unlike the Dbl oncoprotein, which requires the presence of (free) guanine nucleotide in the medium to replace the GDP bound to Cdc42Hs, PIP2 stimulates GDP release from Cdc42Hs in the absence of free guanine nucleotide. PIP2, when incorporated into phosphatidylcholine carrier vesicles, binds tightly to the guanine nucleotide-depleted form of Cdc42Hs and weakly to the GDP-bound form of the GTP-binding protein but does not bind to GTP-bound Cdc42Hs, similar to what was observed for the Dbl oncoprotein. However, mutational analysis of Cdc42Hs indicates that the site that is essential for the functional interaction between PIP2 and Cdc42Hs is distinct from the Dbl-binding site and is located at the positively charged carboxyl-terminal end of the GTP-binding protein. The GDP-releasing activity of PIP2 is highly effective toward Cdc42Hs and Rho (and is similar to the reported effects of PIP2 on Arf (Terui, T., Kahn, R. A., and Randazzo, P. A., (1994) J. Biol. Chem. 269, 28130-28135)), is less effective with Rac, and is not observed with Ras, Rap1a, or Ran. The ability of PIP2 to activate Cdc42Hs (or Rho) and Arf provides a possible point of convergence for the biological pathways regulated by these different GTP-binding proteins and may be related to the synergism observed between Arf and Rho-subtype proteins in the stimulation of phospholipase D activity (Singer, W. D., Brown, H. A., Bokoch, G. M., and Sternweis, P. C. (1995) J. Biol. Chem. 270, 14944-14950).
Ras相关GTP结合蛋白的Rho亚家族成员在肌动蛋白细胞骨架的组织以及细胞生长的调节中发挥着重要作用。我们之前已经表明,作为一类生长调节蛋白原型的dbl癌基因产物,通过催化GDP从其核苷酸结合位点解离来激活Rho亚家族GTP结合蛋白。在本研究中,我们证明酸性磷脂磷脂酰肌醇4,5-二磷酸(PIP2)为Cdc42Hs的激活提供了一种替代机制。在测试的多种脂质中,只有PIP2能够以剂量依赖的方式刺激Cdc42Hs释放GDP,在约50 microM时达到最大效应的一半。与需要培养基中存在(游离)鸟嘌呤核苷酸来取代与Cdc42Hs结合的GDP的Dbl癌蛋白不同,PIP2在没有游离鸟嘌呤核苷酸的情况下刺激Cdc42Hs释放GDP。当PIP2掺入磷脂酰胆碱载体囊泡中时,它与鸟嘌呤核苷酸耗尽形式的Cdc42Hs紧密结合,与GTP结合蛋白的GDP结合形式弱结合,但不与GTP结合的Cdc42Hs结合,这与Dbl癌蛋白的情况类似。然而,对Cdc42Hs的突变分析表明,PIP2与Cdc42Hs功能相互作用所必需的位点与Dbl结合位点不同,位于GTP结合蛋白带正电荷的羧基末端。PIP2的GDP释放活性对Cdc42Hs和Rho非常有效(并且类似于报道的PIP2对Arf的作用(Terui, T., Kahn, R. A., and Randazzo, P. A., (1994) J. Biol. Chem. 269, 28130 - 28135)),对Rac的效果较差,对Ras、Rap1a或Ran则未观察到这种活性。PIP2激活Cdc42Hs(或Rho)和Arf的能力为这些不同GTP结合蛋白调节的生物途径提供了一个可能的交汇点,并且可能与在刺激磷脂酶D活性中观察到的Arf和Rho亚型蛋白之间的协同作用有关(Singer, W. D., Brown, H. A., Bokoch, G. M., and Sternweis, P. C. (1995) J. Biol. Chem. 270, 14944 - 14950)。